12th May 2008 07:20
TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing Advanced Medical Solutions shares to which voting rights are attached: 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to notification AXA S.A. 25 Avenue Matignon, 75008 Paris and its obligation: group of companies 4. Full name of shareholder(s) (if different from 3): 5. Date of transaction (and date on which the 8 May 2008 threshold is crossed or reached if different): 6. Date on which issuer notified: 9 May 2008 7. Threshold(s) that is/are crossed or reached: 13% 8: Notified Details A: Voting rights attached to shares Class/type of Situation previous to the Resulting situation after the triggering transaction shares triggering transaction Number of Number of Number of Number of voting rights Percentage of voting If possible use shares voting shares rights ISIN code rights Direct Indirect Direct Indirect Ordinary 5p shares 19,182,218 19,182,218 415,161 415,161 18,167,057 0.29 12.68 GB0004536594 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting instrument period/date that may be acquired rights (if the instrument exercised/converted) Total (A+B) Number of voting rights Percentage of voting rights 18,582,218 12.97% 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: Name of the Company/Fund No of shares % of issued share cap Sun Life Pensions Mgmt Ltd 15,161 0.01 Direct Sun Life Pensions Mgmt Ltd 400,000 0.28 Direct AXA Framlington 10,000,000 6.99 Framlington Innovative Growth Indirect AXA Framlington 5,100,000 3.56 Health Indirect Framlington onshore private clients 2,701,500 1.89 Indirect AWF Framlington Health 365,557 0.26 Indirect Total Direct 415,161 0.29 Total Indirect 18,167,057 12.68 Total 18,582,218 13.36 Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/A to hold: 12. Date on which proxy holder will cease to hold N/A voting rights: 13. Additional information: 14 Contact name: Mary TavenerRelated Shares:
Advanced Medical Solutions Group